|

iMAB Clinical Trials

1 actively recruiting trial

Also known as: intermittent maximum androgen blockade

Pipeline

Phase 3: 1

Top Sponsors

  • European Organisation for Research and Treatment of Cancer - EORTC1

Indications

  • Prostate Cancer1
  • Cancer1

Other1 trial

Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.